140 related articles for article (PubMed ID: 36224008)
1. PGAM1 Promotes Glycolytic Metabolism and Paclitaxel Resistance via Pyruvic Acid Production in Ovarian Cancer Cells.
Feng Y; Zhang X; Zhang S; Xu S; Chen X; Zhou C; Xi Y; Xie X; Lu W
Front Biosci (Landmark Ed); 2022 Sep; 27(9):262. PubMed ID: 36224008
[TBL] [Abstract][Full Text] [Related]
2. Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.
Fu Y; Ye D; Chen H; Lu W; Ye F; Xie X
Gynecol Oncol; 2007 Apr; 105(1):66-73. PubMed ID: 17234259
[TBL] [Abstract][Full Text] [Related]
3. PGAM1 regulates the glycolytic metabolism of SCs in tibetan sheep and its influence on the development of SCs.
An X; Li T; Chen N; Wang H; Wang X; Ma Y
Gene; 2021 Dec; 804():145897. PubMed ID: 34418471
[TBL] [Abstract][Full Text] [Related]
4. Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
Vander Heiden MG; Locasale JW; Swanson KD; Sharfi H; Heffron GJ; Amador-Noguez D; Christofk HR; Wagner G; Rabinowitz JD; Asara JM; Cantley LC
Science; 2010 Sep; 329(5998):1492-9. PubMed ID: 20847263
[TBL] [Abstract][Full Text] [Related]
5. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C; Li Y; Zhao W; Liu G; Yang Q
Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of glycogen synthase kinase-3 in ovarian carcinoma cells with acquired paclitaxel resistance.
Fu Y; Hu D; Qiu J; Xie X; Ye F; Lu WG
Int J Gynecol Cancer; 2011 Apr; 21(3):439-44. PubMed ID: 21436692
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of UTP23 promotes paclitaxel resistance and predicts poorer prognosis in ovarian cancer.
Fu Z; Wang C; Chen Y; Zhang X; Wang X; Xie X
Pathol Res Pract; 2019 Nov; 215(11):152625. PubMed ID: 31540773
[TBL] [Abstract][Full Text] [Related]
8. Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity.
Zhang D; Jin N; Sun W; Li X; Liu B; Xie Z; Qu J; Xu J; Yang X; Su Y; Tang S; Han H; Chen D; Ding J; Tan M; Huang M; Geng M
Oncogene; 2017 May; 36(20):2900-2909. PubMed ID: 27991922
[TBL] [Abstract][Full Text] [Related]
9. [Reversing paclitaxel-resistance of SKOV3-TR30 cell line by curcumin].
Qiu J; Fu YF; Cheng Q; Cheng XD; Xie X; Lü WG
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(27):1926-8. PubMed ID: 23134969
[TBL] [Abstract][Full Text] [Related]
10. TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer.
Zhang SF; Wang XY; Fu ZQ; Peng QH; Zhang JY; Ye F; Fu YF; Zhou CY; Lu WG; Cheng XD; Xie X
Autophagy; 2015; 11(2):225-38. PubMed ID: 25607466
[TBL] [Abstract][Full Text] [Related]
11. Phosphoglycerate mutase 1 in cancer: A promising target for diagnosis and therapy.
Sharif F; Rasul A; Ashraf A; Hussain G; Younis T; Sarfraz I; Chaudhry MA; Bukhari SA; Ji XY; Selamoglu Z; Ali M
IUBMB Life; 2019 Oct; 71(10):1418-1427. PubMed ID: 31169978
[TBL] [Abstract][Full Text] [Related]
12. ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel.
Li S; Zhao X; Chang S; Li Y; Guo M; Guan Y
Int J Oncol; 2019 Jan; 54(1):249-260. PubMed ID: 30431082
[TBL] [Abstract][Full Text] [Related]
13. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
[TBL] [Abstract][Full Text] [Related]
14. The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.
Jiang X; Sun Q; Li H; Li K; Ren X
Int J Cancer; 2014 Nov; 135(9):1991-6. PubMed ID: 24285383
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphoglycerate mutase controls serine pathway flux via 3-phosphoglycerate.
Oslund RC; Su X; Haugbro M; Kee JM; Esposito M; David Y; Wang B; Ge E; Perlman DH; Kang Y; Muir TW; Rabinowitz JD
Nat Chem Biol; 2017 Oct; 13(10):1081-1087. PubMed ID: 28805803
[TBL] [Abstract][Full Text] [Related]
16. Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells.
Qu J; Sun W; Zhong J; Lv H; Zhu M; Xu J; Jin N; Xie Z; Tan M; Lin SH; Geng M; Ding J; Huang M
J Cell Biol; 2017 Feb; 216(2):409-424. PubMed ID: 28122957
[TBL] [Abstract][Full Text] [Related]
17. Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis.
Sun Q; Li S; Wang Y; Peng H; Zhang X; Zheng Y; Li C; Li L; Chen R; Chen X; Bai W; Jiang X; Liu L; Wei F; Wang B; Zhang Y; Li H; Ren X; Zhang H
Cell Death Differ; 2018 Jun; 25(6):1160-1173. PubMed ID: 29362480
[TBL] [Abstract][Full Text] [Related]
18. Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation.
Hallows WC; Yu W; Denu JM
J Biol Chem; 2012 Feb; 287(6):3850-8. PubMed ID: 22157007
[TBL] [Abstract][Full Text] [Related]
19. Glucose deprivation enhances resistance to paclitaxel via ELAVL2/4-mediated modification of glycolysis in ovarian cancer cells.
Park GB; Jeong JY; Choi S; Yoon YS; Kim D
Anticancer Drugs; 2022 Jan; 33(1):e370-e380. PubMed ID: 34419957
[TBL] [Abstract][Full Text] [Related]
20. Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation.
Hitosugi T; Zhou L; Fan J; Elf S; Zhang L; Xie J; Wang Y; Gu TL; Alečković M; LeRoy G; Kang Y; Kang HB; Seo JH; Shan C; Jin P; Gong W; Lonial S; Arellano ML; Khoury HJ; Chen GZ; Shin DM; Khuri FR; Boggon TJ; Kang S; He C; Chen J
Nat Commun; 2013; 4():1790. PubMed ID: 23653202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]